J&J to pump another $13B into its MedTech business with Shockwave deal
Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles
Ecuador announces complaint against Mexico at top UN court in diplomatic spat
QUITO, Ecuador (AP) — Ecuador announced Monday it has filed a complaint at the top U.N. court agains2024-04-30- Xuzhou is a major city in east China's Jiangsu province with a time-honored history and splendid cul2024-04-30
Interview: Zheng Qinwen: Keep my eyes on the sky and feet on the ground
(Xinhua) 13:22, September 19, 2023BEIJING, Sept. 19 (Xinhua) -- The Hangzhou Asian Games will be the2024-04-30Chase Elliott drives backward after Texas win that could get him going in the right direction again
FORT WORTH, Texas (AP) — Chase Elliott drove backward on the track after an emotional victory that c2024-04-30US opens investigation into Ford crashes involving Blue Cruise partially automated driving system
DETROIT (AP) — Two fatal crashes involving Ford’s Blue Cruise partially automated driving system hav2024-04-30Ice and snow metaverse experience center in Harbin draws attention
This photo taken on Feb. 12, 2023 shows the Harbin Ice and Snow World seen from a VR device at an ic2024-04-30
atest comment